MARRADI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 8.192
EU - Europa 4.376
AS - Asia 2.910
SA - Sud America 813
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 120
OC - Oceania 23
Totale 16.719
Nazione #
US - Stati Uniti d'America 8.007
IT - Italia 1.214
RU - Federazione Russa 1.211
CN - Cina 667
SG - Singapore 657
BR - Brasile 644
PL - Polonia 610
VN - Vietnam 492
HK - Hong Kong 431
IE - Irlanda 348
SE - Svezia 286
KR - Corea 249
CH - Svizzera 139
FR - Francia 121
CA - Canada 106
FI - Finlandia 94
DE - Germania 86
ID - Indonesia 80
UA - Ucraina 76
IN - India 72
AR - Argentina 71
JP - Giappone 62
GB - Regno Unito 59
BD - Bangladesh 55
MX - Messico 37
NG - Nigeria 32
NL - Olanda 29
ES - Italia 25
EC - Ecuador 24
CI - Costa d'Avorio 23
CO - Colombia 22
AU - Australia 21
BG - Bulgaria 21
TR - Turchia 20
IQ - Iraq 16
JO - Giordania 15
ZA - Sudafrica 15
BE - Belgio 12
PY - Paraguay 12
PK - Pakistan 11
VE - Venezuela 11
AT - Austria 10
CL - Cile 10
MA - Marocco 10
PE - Perù 9
SA - Arabia Saudita 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
EG - Egitto 8
UY - Uruguay 8
AZ - Azerbaigian 7
MY - Malesia 7
CR - Costa Rica 6
SC - Seychelles 6
BJ - Benin 5
CZ - Repubblica Ceca 5
IR - Iran 5
JM - Giamaica 5
RO - Romania 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
LB - Libano 4
OM - Oman 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
IL - Israele 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
UZ - Uzbekistan 3
AL - Albania 2
CU - Cuba 2
CY - Cipro 2
KH - Cambogia 2
LT - Lituania 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
GF - Guiana Francese 1
GR - Grecia 1
HT - Haiti 1
Totale 16.417
Città #
Santa Clara 2.284
Ashburn 844
Fairfield 763
Warsaw 603
Singapore 508
Hong Kong 353
Dublin 344
Woodbridge 330
Seattle 317
Houston 285
Cambridge 266
Wilmington 235
Milan 231
Seoul 227
San Jose 212
Florence 184
Ho Chi Minh City 176
Council Bluffs 166
Chandler 164
Beijing 155
Altamura 140
Lawrence 138
Bern 135
Ann Arbor 119
Rome 118
Hanoi 110
Los Angeles 109
Hefei 96
Lauterbourg 92
Princeton 83
Jacksonville 76
Moscow 74
The Dalles 72
Boston 69
Buffalo 64
Tokyo 60
Clifton 52
São Paulo 51
Jakarta 44
San Diego 41
Medford 40
Phoenix 40
Helsinki 39
Mumbai 36
Lappeenranta 34
Abuja 32
New York 32
Dallas 30
Naples 27
Shanghai 27
Boardman 25
Abidjan 23
Haiphong 23
Figino 22
Norwalk 22
Rio de Janeiro 22
Sofia 21
Chicago 20
Dong Ket 20
Kent 20
Melbourne 20
Toronto 20
Turin 19
Atlanta 17
Curitiba 17
Da Nang 17
Belo Horizonte 16
Bologna 16
Barcelona 15
Dearborn 15
Miano 15
Munich 15
Montreal 14
Palermo 14
Andover 13
Brasília 13
Campinas 13
Genoa 13
Shenzhen 13
Stockholm 13
Biên Hòa 12
Guangzhou 12
Orem 12
Bogotá 11
Columbus 11
London 11
Redondo Beach 11
Arezzo 10
Baghdad 10
Brussels 10
Falls Church 10
Frankfurt am Main 10
Mexico City 10
Quito 10
Vienna 10
Bengaluru 9
Hillsboro 9
Hải Dương 9
Porto Alegre 9
Yubileyny 9
Totale 11.458
Nome #
Synthesis of densely functionalized enantiopure indolizidines by ring-closing metathesis (RCM) of hydroxylamines from carbohydrate-derived nitrones 326
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection 280
The B & B approach: Ball-milling conjugation of dextran with phenylboronic acid (PBA)-functionalized BODIPY 280
Fabrication of hybrid graphene oxide/polyelectrolyte capsules by means of layer-by-layer assembly on erythrocyte cell templates 255
Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities 246
GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination 239
Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine 238
Multimerization of DAB-1 onto Au GNPs affords new potent and selective N-acetylgalactosamine-6-sulfatase (GALNS) inhibitors 235
On the Virtue of Indium in Reduction Reactions. A Comparison of Reductions Mediated by Indium and Zinc: Is Indium Metal an Effective Catalyst for Zinc Induced Reductions? 228
A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study 221
Formal Mixed Double Addition to N-Glycosyl Nitrones through Addition–Oxidation–Addition to N-Glycosylhydroxylamines 213
Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells 213
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs 212
Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses 209
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles 206
Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model 204
Gold nanoparticles decorated with monosaccharides and sulfated ligands as potential modulators of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS) 202
Carbohydrate-based nanoparticles for potential applications in medicine 193
Practical Synthesis of N-Alkyl-N-glycosylhydroxylamines, Multitalented Precursors of Enantiomerically Pure Nitrones 190
Double Addition of Grignard Reagents to N-Glycosyl Nitrones: a New Tool for the Construction of Enantiopure Azaheterocycles 190
Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas 187
Cytotoxicity testing of therapeutic nanosystems for pulmonary infection using an air-lifted interphase in-vitro test system 186
Glyconanoparticles: multifunctional nanomaterials for biomedical applications 185
Glycoliposomes and metallic glyconanoparticles in glycoscience 185
Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo 182
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 182
Hybrid Multivalent Jack Bean alpha-Mannosidase Inhibitors: The First Example of Gold Nanoparticles Decorated with Deoxynojirimycin Inhitopes 182
Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy 179
N-Glycosylhydroxylamines as masked polyhydroxylated chiral nitrones in cycloaddition reactions: an access to pyrrolizidines 178
A quantitative study of the intracellular dynamics of fluorescently labelled glyco-gold nanoparticles via fluorescence correlation spectroscopy 178
Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes 178
Glyconanoparticles as multifunctional and multimodal carbohydrate systems 176
Gold nanoparticles are suitable cores for building tunable iminosugar multivalency 171
Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents 170
A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands 170
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma 169
Manganese Dioxide Oxidation of Hydroxylamines to Nitrones 168
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine 168
Carbohydrate Functionalized Quantum Dots in Sensing, Imaging and Therapy Applications 167
Molybdenum Hexacarbonyl [Mo(CO)6] 165
Coloranti naturalizzati: una nuova opportunità per la colorazione del legno 163
Novel Core–Shell Polyamine Phosphate Nanoparticles Self-Assembled from PEGylated Poly(allylamine hydrochloride) with Low Toxicity and Increased In Vivo Circulation Time 163
Chapter 5. Glyconanotechnology and Disease: Gold Nanoparticles Coated with Glycosides as Multivalent Systems for Potential Applications in Diagnostics and Therapy 162
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 162
Recent advances on smart glycoconjugate vaccines in infections and cancer 162
Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN 162
Loading Dendritic Cells with Gold Nanoparticles (GNPs) Bearing HIV-peptides and Mannosides Enhance HIV-specific T Cell Responses 162
Supramolecular dextran/polyamine phosphate nanocapsules with smart responsiveness for encapsulation of therapeutics 161
Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines 161
Novel nanoparticle vaccines for Listeriosis 161
A PROCESS FOR PREPARING WATER-DISPERSIBLE SINGLE-CHAIN POLYMERIC NANOPARTICLES 157
Sugar/gadolinium-loaded gold nanoparticles for labelling and imaging cells by magnetic resonance imaging 157
Visualisation of dual radiolabelled poly(lactide-co-glycolide) nanoparticle degradation in vivo using energy-discriminant SPECT 156
Naturalized Dyes: A New Opportunity for the Wood Coloring 155
Synthesis and functionalization of dextran-based single-chain nanoparticles in aqueous media 154
Radiolabelling of NPs Using Radiometals: 99mTc, 68Ga, 67Ga, 89Zr, and 64Cu 154
Multivalent glycoconjugates as anti-pathogenic agents 153
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN 152
Simple engineering of hybrid cellulose nanocrystal-gold nanoparticles results in a functional glyconanomaterial with biomolecular recognition properties 151
Interfacial activity of modified Dextran polysaccharide to produce enzyme-responsive oil-in-water nanoemulsions 151
Multivalent iminosugars as enhancers of the lysosomal enzyme GCase activity 150
Recent developments in the reduction of oxidative stress through antioxidant polymeric formulations 149
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12 149
Influence of ligand presentation density on the molecular recognition of mannose-functionalised glyconanoparticles by bacterial lectin BC2L-A 149
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma 149
Nano-antibiotics based on single-chain dextran nanoparticles 149
Neutralization of ionic interactions by dextran-based single-chain nanoparticles improves tobramycin diffusion into a mature biofilm 149
New Highly Strained Multifunctional Heterocycles by Intramolecular Cycloaddition of Nitrones to Bicyclopropylidene Moieties 147
In vivo stability of protein coatings on poly lactic co glycolic nanoparticles 147
STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans 147
Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors 147
Glyconanoparticles: New Nanomaterials for Biological Applications 146
Radiolabelling of Nanoparticles Using Radiohalogens, 13N, and 11C 146
MULTIVALENT VACCINE FOR THE TREATMENT AND PREVENTION OF TUBERCULOSIS, LISTERIOSIS AND PNEUMONIA 146
Nucleophilic Additions to Cyclic Nitrones en route to Iminocyclitols - Straightforward Total Syntheses of DMDP, 6-deoxy-DMDP, DAB-1, CYB-3, Nectrisine, and Radicamine B 145
Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars 145
Emerging glyco-based strategies to steer immune responses 145
Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL 143
New Oligocyclic beta-Lactams and beta-Amino Acids by Intramolecular Cycloaddition of Bicyclopropylidenyl-Substituted Nitrones 142
Preparation of N-Glycosylhydroxylamines and Their Oxidation to Nitrones for the Enantioselective Synthesis of Isoxazolidines 141
Straightforward Synthesis of Enantiopure 2-Aminomethyl and 2-Hydroxymethyl Pyrrolidines with Complete Stereocontrol 139
Therapeutic efficacy of novel antimicrobial peptide AA139-nanomedicines in a multidrug-resistant klebsiella pneumoniae pneumonia-septicemia model in rats 139
Gold Nanoparticles as Scaffolds for the Multimerization of Iminosugars: New Multivalent Modulators of the Enzyme GCase 136
USE OF A GNP-LLO91-99 COMPLEX FOR THE TREATMENT AND PREVENTION OF CANCER 134
Low-generation dendrimers with a calixarene core and based on a chiral C2-symmetric pyrrolidine as iminosugar mimics 133
Glyconanoparticles polyvalent tools to study carbohydrate-based interactions 133
Glycan-stabilized plasmonic nanoparticles: An attractive nanomaterial for bio-applications 132
New chiral nitrones for stereoselective syntheses of biologically active natural products and their analogues 129
One-Pot Synthesis of Cyclic Nitrones and Their Conversion to New Pyrrolizidines: 7a-epi-Crotanecine Inhibits α-Mannosidases 128
New multivalent glycosidase inhibitors: exploring different iminosugars and scaffolds 115
Dual-Targeting Gold Nanoparticles: Simultaneous Decoration with Ligands for Co-Transporters SGLT-1 and B0AT1 115
Multivalent GCase enhancers: synthesis and evaluation of glyco- gold nanoparticles decorated with trihydroxypiperidine iminosugars 113
Multivalent 2-alkyl trihydroxypiperidines as potential enhancers of the β-glucocerebrosidase enzyme activity 110
Gold nanoparticles and lipid vesicles: a gateway to advanced nanoplasmonic and SERS probes for biomedical applications 101
Tobramycin nanoformulation for chronic pulmonary infections: From drug product definition to scale-up for preclinical evaluation 83
Galactose‐Functionalized Gold Nanoparticles Targeting Membrane Transporters for the Glutathione Delivery to Brain Cancer Cells 68
Engineering biomimetic lipid interfaces to form smart materials 55
Glyconanocapsules with pH Responsiveness for Encapsulation and Smart Delivery of Therapeutics 54
Multivalent sugars and glycomimetics as enzyme stabilizers for lysosomal storage diseases 52
Dextran-Modified Poly(allylamine) Nanoparticles as Nanocarriers for the Delivery of Enzymes involved in Lysosomal Storage Diseases 51
Totale 16.316
Categoria #
all - tutte 44.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022562 0 0 80 29 14 41 55 39 34 31 72 167
2022/20231.433 177 354 65 50 54 219 201 48 86 6 34 139
2023/2024414 17 41 105 20 37 40 18 56 7 37 24 12
2024/20254.541 117 361 204 469 1.466 1.138 82 281 105 70 117 131
2025/20265.317 385 600 441 866 434 150 535 338 345 341 151 731
2026/2027735 266 188 281 0 0 0 0 0 0 0 0 0
Totale 16.719